Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07805369
What this trial is testing

DEM301 in Participants With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerRectal Cancer
DEM BioPharma, Inc. 60
Very early researchEnded earlyNCT00835679
What this trial is testing

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00628368
What this trial is testing

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 160
Large-scale testing (Phase 3)Ended earlyNCT00023868
What this trial is testing

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Who this might be right for
Colorectal CancerMetastatic Cancer
American College of Radiology Imaging Network
Not applicableWithdrawnNCT06217016
What this trial is testing

Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2)

Who this might be right for
Urinary RetentionRectal CancerUrinary Catheterization
The First Hospital of Jilin University
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Testing effectiveness (Phase 2)WithdrawnNCT00408772
What this trial is testing

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06665087
What this trial is testing

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Who this might be right for
Colon CancerRectal Cancer
Fudan University 110
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Not applicableUnknownNCT04634526
What this trial is testing

Prospective Clinical Study of Intraoperative Assessment of Resection Margin of Colo-Rectal Cancer Liver Metastases

Who this might be right for
Liver Metastasis Colon Cancer
Oncology Institute of Vojvodina 250
Early research (Phase 1)Study completedNCT00084643
What this trial is testing

GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIC Colon Cancer+6 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00049335
What this trial is testing

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 29
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003753
What this trial is testing

Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00005818
What this trial is testing

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)UnknownNCT00122291
What this trial is testing

Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerNeoplasm Metastasis
Alberta Health services 66
Next Page